SUBSTITUTED HETEROCYCLIC COMPOUNDS AS SIRTUIN INHITIBITORS
摘要
<p>Compound of formula (I) and methods of treating disorders by administering a compound of formula (I) are described herein. Examples of disorders include neoplastic disorders, fat-cell related disorders, neurodegenerative disorders, and metabolic disorders.</p>
申请公布号
CA2538759(C)
申请公布日期
2015.11.03
申请号
CA20042538759
申请日期
2004.09.13
申请人
ELIXIR PHARMACEUTICALS, INC.
发明人
NAPPER, ANDREW;DISTEFANO, PETER;HIXON, JEFFREY;MCDONAGH, THOMAS;SOLOMON, JONATHAN M.;HUBER, L. JULIE;CURTIS, RORY;THOMAS, RUSSELL J.;PONS, JEAN-FRANCOIS
